Standard BioTools
Standard BioTools Inc., previously known as Fluidigm Corp., offers analytical mass cytometry systems for flow cytometry and tissue imaging, along with associated assays and reagents, as well as an automated genomic analysis instrument and a variety of microfluidic arrays, or integrated fluidic circuits (IFCs), and consumables with fully kitted reagents. Custom assays and services are available with all systems and applications.
| Formerly |
|
|---|---|
| Company type | Public |
| |
| Founded | 1999 |
| Headquarters | , United States |
Key people | Michael Egholm (President & CEO) |
| Revenue | US$130.6 million (2021) |
Number of employees | 615 (December 2021) |
| Website | www |
Standard BioTools sells products to academic research institutions; translational research and medical centers; cancer centers; clinical research laboratories; biopharmaceutical, biotechnology and plant and animal research companies; and contract research organizations.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.